THINK Surgical Secures Up to $65 Million in Growth Capital from Symbiotic Capital
THINK Surgical has entered into a debt facility with Symbiotic Capital that will provide up to $65 million in growth capital, announced in a press release. The agreement includes an initial $25 million tranche, with an additional $15 million tied to milestones and a further $25 million available at Symbiotic Capital’s discretion.
The funds will support THINK Surgical’s dual channel commercial strategy for its TMINI Miniature Robotic System, which is compatible with about 70% of total knee implant market share. The company stated that this facility, combined with recent investor support, is expected to fund operations through profitability.
Symbiotic Capital said it was impressed by TMINI’s design and its potential to advance orthopedic surgical robotics. Piper Sandler acted as the financial advisor for THINK Surgical in this transaction.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Robotics Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Robotics
More from: Life Sciences
Subscribe to Robotics Brief
Weekly coverage of AI-driven robotics advances in industrial automation, autonomous vehicles, and robotic systems.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more